INHIBITION OF THE IRE1ALPHA-XBP1 PATHWAY USING TOYOCAMYCIN AS A NOVEL WAY TO INHIBIT PROGRESSION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY AND LIVER DISEASE

Yale Univ

Investigators